HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Emerging Therapeutic Modalities

Emerging therapeutic modalities bring innovative approaches to cancer treatment. Gene therapy, using tools like CRISPR-Cas9, corrects genetic mutations or enhances immune responses, offering precision in targeting cancer cells. RNA-based therapies, including siRNA and mRNA platforms, regulate cancer-driving pathways effectively. Epigenetic therapies aim to reverse aberrant DNA methylation and histone modifications, restoring normal gene expression. Non-invasive options like photodynamic therapy use light-activated compounds to destroy tumors selectively. Thermal ablation employs controlled heat to target and eliminate cancer cells while sparing healthy tissues. These modalities, often combined with traditional treatments, expand the possibilities for personalized, effective, and less invasive cancer care, promising better outcomes for patients.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp